Mazor Robotics, Israeli developer of surgical robots and complementary products for spine surgery, signed an agreement with Cicel Science & Technology to distribute its Renaissance system in China. As part of the agreement, Cicel is committed to purchase three Renaissance systems for surgical guidance and will use these systems to pursue regulatory clearance from the State Food and Drug Administration (SFDA) in China. View and share
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments